HEADER HYDROLASE/ANTIBIOTIC 11-NOV-15 5EPH TITLE CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 IN COMPLEX TITLE 2 WITH IMIPENEM COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 19-238; COMPND 5 SYNONYM: EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1; COMPND 6 EC: 3.5.2.6; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: BLA(BEL1), BLABEL-1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET9A KEYWDS HYDROLASE-ANTIBIOTIC COMPLEX, EXTENDED-SPECTRUM BETA-LACTAMASE, KEYWDS 2 PSEUDOMONAS AERUGINOSA EXPDTA X-RAY DIFFRACTION AUTHOR C.POZZI,M.BENVENUTI,F.DE LUCA,J.D.DOCQUIER,S.MANGANI REVDAT 5 10-JAN-24 5EPH 1 REMARK REVDAT 4 31-JAN-18 5EPH 1 SOURCE REVDAT 3 07-DEC-16 5EPH 1 JRNL REVDAT 2 05-OCT-16 5EPH 1 JRNL REVDAT 1 21-SEP-16 5EPH 0 SPRSDE 21-SEP-16 5EPH 4MXB JRNL AUTH C.POZZI,F.DE LUCA,M.BENVENUTI,L.POIREL,P.NORDMANN, JRNL AUTH 2 G.M.ROSSOLINI,S.MANGANI,J.D.DOCQUIER JRNL TITL CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA BEL-1 JRNL TITL 2 EXTENDED-SPECTRUM BETA-LACTAMASE AND ITS COMPLEXES WITH JRNL TITL 3 MOXALACTAM AND IMIPENEM. JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 60 7189 2016 JRNL REFN ESSN 1098-6596 JRNL PMID 27671060 JRNL DOI 10.1128/AAC.00936-16 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 87230 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4579 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6692 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE SET COUNT : 329 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7862 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 685 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.124 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.119 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.481 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8131 ; 0.017 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 7827 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11029 ; 1.767 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 17975 ; 0.961 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1049 ; 6.110 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 342 ;37.848 ;24.006 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1366 ;12.442 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 58 ;19.370 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1285 ; 0.107 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 9242 ; 0.011 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1810 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4151 ; 1.653 ; 1.906 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 4150 ; 1.652 ; 1.906 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5182 ; 2.319 ; 2.846 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 5183 ; 2.319 ; 2.846 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3980 ; 2.212 ; 2.169 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 3981 ; 2.212 ; 2.169 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 5837 ; 3.323 ; 3.156 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 9734 ; 4.932 ;16.180 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 9735 ; 4.932 ;16.184 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5EPH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215307. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-APR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 - 6.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : SI(311) AND SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 91836 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 51.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.38800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 5EOE REMARK 200 REMARK 200 REMARK: PLATE-SHAPED CRYSTALS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG4600, 20% MPD, 0.1M SODIUM REMARK 280 CITRATE, PH 5.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.93000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 19 REMARK 465 ALA A 20 REMARK 465 THR A 164 REMARK 465 ASN A 165 REMARK 465 GLN B 19 REMARK 465 ALA B 20 REMARK 465 GLU B 159 REMARK 465 PRO B 160 REMARK 465 THR B 161 REMARK 465 LEU B 162 REMARK 465 ASN B 163 REMARK 465 THR B 164 REMARK 465 ASN B 165 REMARK 465 VAL B 282 REMARK 465 HIS B 283 REMARK 465 GLN C 19 REMARK 465 ALA C 20 REMARK 465 THR C 164 REMARK 465 ASN C 165 REMARK 465 THR C 166 REMARK 465 PRO C 167 REMARK 465 VAL C 282 REMARK 465 HIS C 283 REMARK 465 GLN D 19 REMARK 465 ALA D 20 REMARK 465 HIS D 283 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 34 CD OE1 NE2 REMARK 470 GLU A 80 OE1 OE2 REMARK 470 GLU A 96 CD OE1 OE2 REMARK 470 LYS A 151 CD CE NZ REMARK 470 LYS A 195 NZ REMARK 470 LYS A 212 CE NZ REMARK 470 GLU A 264 CD OE1 OE2 REMARK 470 LYS B 143 CE NZ REMARK 470 LYS B 151 CE NZ REMARK 470 ARG B 157 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 248 CE NZ REMARK 470 GLU B 264 CG CD OE1 OE2 REMARK 470 LYS C 151 CD CE NZ REMARK 470 GLU C 170 CG CD OE1 OE2 REMARK 470 LYS C 248 CD CE NZ REMARK 470 GLN D 34 CD OE1 NE2 REMARK 470 GLU D 96 CD OE1 OE2 REMARK 470 LYS D 151 CD CE NZ REMARK 470 ARG D 157 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 248 CD CE NZ REMARK 470 GLU D 260 CD OE1 OE2 REMARK 470 GLN D 262 CD OE1 NE2 REMARK 470 VAL D 282 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP D 77 O HOH D 401 1.94 REMARK 500 OE1 GLU B 81 OE2 GLU B 134 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 60 52.13 -101.02 REMARK 500 SER A 62 -31.69 -135.89 REMARK 500 ALA A 98 66.52 -152.17 REMARK 500 THR A 213 -125.89 -99.11 REMARK 500 SER B 62 -34.36 -130.48 REMARK 500 ALA B 98 71.64 -158.74 REMARK 500 THR B 213 -124.99 -101.47 REMARK 500 MET C 60 60.65 -107.82 REMARK 500 SER C 62 -34.09 -130.74 REMARK 500 ALA C 98 66.06 -155.50 REMARK 500 THR C 213 -125.48 -106.94 REMARK 500 MET D 60 61.85 -107.29 REMARK 500 ALA D 98 65.92 -162.41 REMARK 500 THR D 213 -121.52 -104.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ID1 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MRD B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ID1 B 302 and SER B REMARK 800 62 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ID1 C 302 and SER C REMARK 800 62 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ID1 D 302 and SER D REMARK 800 62 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5EOO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 REMARK 900 (MONOCLINIC FORM) REMARK 900 RELATED ID: 5EOE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 REMARK 900 (ORTHORHOMBIC FORM) DBREF 5EPH A 19 283 UNP Q3SAW3 Q3SAW3_PSEAI 19 283 DBREF 5EPH B 19 283 UNP Q3SAW3 Q3SAW3_PSEAI 19 283 DBREF 5EPH C 19 283 UNP Q3SAW3 Q3SAW3_PSEAI 19 283 DBREF 5EPH D 19 283 UNP Q3SAW3 Q3SAW3_PSEAI 19 283 SEQRES 1 A 265 GLN ALA ASP PHE GLU HIS ALA ILE SER ASP LEU GLU ALA SEQRES 2 A 265 HIS ASN GLN ALA LYS ILE GLY VAL ALA LEU VAL SER GLU SEQRES 3 A 265 ASN GLY ASN LEU ILE GLN GLY TYR ARG ALA ASN GLU ARG SEQRES 4 A 265 PHE ALA MET CYS SER THR PHE LYS LEU PRO LEU ALA ALA SEQRES 5 A 265 LEU VAL LEU SER ARG ILE ASP ALA GLY GLU GLU ASN PRO SEQRES 6 A 265 GLU ARG LYS LEU HIS TYR ASP SER ALA PHE LEU GLU GLU SEQRES 7 A 265 TYR ALA PRO ALA ALA LYS ARG TYR VAL ALA THR GLY TYR SEQRES 8 A 265 MET THR VAL THR GLU ALA ILE GLN SER ALA LEU GLN LEU SEQRES 9 A 265 SER ASP ASN ALA ALA ALA ASN LEU LEU LEU LYS GLU VAL SEQRES 10 A 265 GLY GLY PRO PRO LEU LEU THR LYS TYR PHE ARG SER LEU SEQRES 11 A 265 GLY ASP LYS VAL SER ARG LEU ASP ARG ILE GLU PRO THR SEQRES 12 A 265 LEU ASN THR ASN THR PRO GLY ASP GLU ARG ASP THR THR SEQRES 13 A 265 THR PRO MET SER MET ALA GLN THR VAL SER LYS LEU ILE SEQRES 14 A 265 PHE GLY ASP THR LEU THR TYR LYS SER LYS GLY GLN LEU SEQRES 15 A 265 ARG ARG LEU LEU ILE GLY ASN GLN THR GLY ASP LYS THR SEQRES 16 A 265 ILE ARG ALA GLY LEU PRO ASP SER TRP VAL THR GLY ASP SEQRES 17 A 265 LYS THR GLY SER CYS ALA ASN GLY GLY ARG ASN ASP VAL SEQRES 18 A 265 ALA PHE PHE ILE THR THR ALA GLY LYS LYS TYR VAL LEU SEQRES 19 A 265 SER VAL TYR THR ASN ALA PRO GLU LEU GLN GLY GLU GLU SEQRES 20 A 265 ARG ALA LEU LEU ILE ALA SER VAL ALA LYS LEU ALA ARG SEQRES 21 A 265 GLN TYR VAL VAL HIS SEQRES 1 B 265 GLN ALA ASP PHE GLU HIS ALA ILE SER ASP LEU GLU ALA SEQRES 2 B 265 HIS ASN GLN ALA LYS ILE GLY VAL ALA LEU VAL SER GLU SEQRES 3 B 265 ASN GLY ASN LEU ILE GLN GLY TYR ARG ALA ASN GLU ARG SEQRES 4 B 265 PHE ALA MET CYS SER THR PHE LYS LEU PRO LEU ALA ALA SEQRES 5 B 265 LEU VAL LEU SER ARG ILE ASP ALA GLY GLU GLU ASN PRO SEQRES 6 B 265 GLU ARG LYS LEU HIS TYR ASP SER ALA PHE LEU GLU GLU SEQRES 7 B 265 TYR ALA PRO ALA ALA LYS ARG TYR VAL ALA THR GLY TYR SEQRES 8 B 265 MET THR VAL THR GLU ALA ILE GLN SER ALA LEU GLN LEU SEQRES 9 B 265 SER ASP ASN ALA ALA ALA ASN LEU LEU LEU LYS GLU VAL SEQRES 10 B 265 GLY GLY PRO PRO LEU LEU THR LYS TYR PHE ARG SER LEU SEQRES 11 B 265 GLY ASP LYS VAL SER ARG LEU ASP ARG ILE GLU PRO THR SEQRES 12 B 265 LEU ASN THR ASN THR PRO GLY ASP GLU ARG ASP THR THR SEQRES 13 B 265 THR PRO MET SER MET ALA GLN THR VAL SER LYS LEU ILE SEQRES 14 B 265 PHE GLY ASP THR LEU THR TYR LYS SER LYS GLY GLN LEU SEQRES 15 B 265 ARG ARG LEU LEU ILE GLY ASN GLN THR GLY ASP LYS THR SEQRES 16 B 265 ILE ARG ALA GLY LEU PRO ASP SER TRP VAL THR GLY ASP SEQRES 17 B 265 LYS THR GLY SER CYS ALA ASN GLY GLY ARG ASN ASP VAL SEQRES 18 B 265 ALA PHE PHE ILE THR THR ALA GLY LYS LYS TYR VAL LEU SEQRES 19 B 265 SER VAL TYR THR ASN ALA PRO GLU LEU GLN GLY GLU GLU SEQRES 20 B 265 ARG ALA LEU LEU ILE ALA SER VAL ALA LYS LEU ALA ARG SEQRES 21 B 265 GLN TYR VAL VAL HIS SEQRES 1 C 265 GLN ALA ASP PHE GLU HIS ALA ILE SER ASP LEU GLU ALA SEQRES 2 C 265 HIS ASN GLN ALA LYS ILE GLY VAL ALA LEU VAL SER GLU SEQRES 3 C 265 ASN GLY ASN LEU ILE GLN GLY TYR ARG ALA ASN GLU ARG SEQRES 4 C 265 PHE ALA MET CYS SER THR PHE LYS LEU PRO LEU ALA ALA SEQRES 5 C 265 LEU VAL LEU SER ARG ILE ASP ALA GLY GLU GLU ASN PRO SEQRES 6 C 265 GLU ARG LYS LEU HIS TYR ASP SER ALA PHE LEU GLU GLU SEQRES 7 C 265 TYR ALA PRO ALA ALA LYS ARG TYR VAL ALA THR GLY TYR SEQRES 8 C 265 MET THR VAL THR GLU ALA ILE GLN SER ALA LEU GLN LEU SEQRES 9 C 265 SER ASP ASN ALA ALA ALA ASN LEU LEU LEU LYS GLU VAL SEQRES 10 C 265 GLY GLY PRO PRO LEU LEU THR LYS TYR PHE ARG SER LEU SEQRES 11 C 265 GLY ASP LYS VAL SER ARG LEU ASP ARG ILE GLU PRO THR SEQRES 12 C 265 LEU ASN THR ASN THR PRO GLY ASP GLU ARG ASP THR THR SEQRES 13 C 265 THR PRO MET SER MET ALA GLN THR VAL SER LYS LEU ILE SEQRES 14 C 265 PHE GLY ASP THR LEU THR TYR LYS SER LYS GLY GLN LEU SEQRES 15 C 265 ARG ARG LEU LEU ILE GLY ASN GLN THR GLY ASP LYS THR SEQRES 16 C 265 ILE ARG ALA GLY LEU PRO ASP SER TRP VAL THR GLY ASP SEQRES 17 C 265 LYS THR GLY SER CYS ALA ASN GLY GLY ARG ASN ASP VAL SEQRES 18 C 265 ALA PHE PHE ILE THR THR ALA GLY LYS LYS TYR VAL LEU SEQRES 19 C 265 SER VAL TYR THR ASN ALA PRO GLU LEU GLN GLY GLU GLU SEQRES 20 C 265 ARG ALA LEU LEU ILE ALA SER VAL ALA LYS LEU ALA ARG SEQRES 21 C 265 GLN TYR VAL VAL HIS SEQRES 1 D 265 GLN ALA ASP PHE GLU HIS ALA ILE SER ASP LEU GLU ALA SEQRES 2 D 265 HIS ASN GLN ALA LYS ILE GLY VAL ALA LEU VAL SER GLU SEQRES 3 D 265 ASN GLY ASN LEU ILE GLN GLY TYR ARG ALA ASN GLU ARG SEQRES 4 D 265 PHE ALA MET CYS SER THR PHE LYS LEU PRO LEU ALA ALA SEQRES 5 D 265 LEU VAL LEU SER ARG ILE ASP ALA GLY GLU GLU ASN PRO SEQRES 6 D 265 GLU ARG LYS LEU HIS TYR ASP SER ALA PHE LEU GLU GLU SEQRES 7 D 265 TYR ALA PRO ALA ALA LYS ARG TYR VAL ALA THR GLY TYR SEQRES 8 D 265 MET THR VAL THR GLU ALA ILE GLN SER ALA LEU GLN LEU SEQRES 9 D 265 SER ASP ASN ALA ALA ALA ASN LEU LEU LEU LYS GLU VAL SEQRES 10 D 265 GLY GLY PRO PRO LEU LEU THR LYS TYR PHE ARG SER LEU SEQRES 11 D 265 GLY ASP LYS VAL SER ARG LEU ASP ARG ILE GLU PRO THR SEQRES 12 D 265 LEU ASN THR ASN THR PRO GLY ASP GLU ARG ASP THR THR SEQRES 13 D 265 THR PRO MET SER MET ALA GLN THR VAL SER LYS LEU ILE SEQRES 14 D 265 PHE GLY ASP THR LEU THR TYR LYS SER LYS GLY GLN LEU SEQRES 15 D 265 ARG ARG LEU LEU ILE GLY ASN GLN THR GLY ASP LYS THR SEQRES 16 D 265 ILE ARG ALA GLY LEU PRO ASP SER TRP VAL THR GLY ASP SEQRES 17 D 265 LYS THR GLY SER CYS ALA ASN GLY GLY ARG ASN ASP VAL SEQRES 18 D 265 ALA PHE PHE ILE THR THR ALA GLY LYS LYS TYR VAL LEU SEQRES 19 D 265 SER VAL TYR THR ASN ALA PRO GLU LEU GLN GLY GLU GLU SEQRES 20 D 265 ARG ALA LEU LEU ILE ALA SER VAL ALA LYS LEU ALA ARG SEQRES 21 D 265 GLN TYR VAL VAL HIS HET CL A 301 1 HET CL A 302 1 HET ID1 A 303 20 HET CL B 301 1 HET ID1 B 302 20 HET MRD B 303 8 HET CL C 301 1 HET ID1 C 302 20 HET CL D 301 1 HET ID1 D 302 20 HETNAM CL CHLORIDE ION HETNAM ID1 IMIPENEM HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL FORMUL 5 CL 5(CL 1-) FORMUL 7 ID1 4(C12 H19 N3 O4 S) FORMUL 10 MRD C6 H14 O2 FORMUL 15 HOH *685(H2 O) HELIX 1 AA1 ASP A 21 GLN A 34 1 14 HELIX 2 AA2 PHE A 64 ALA A 78 1 15 HELIX 3 AA3 ASP A 90 LEU A 94 5 5 HELIX 4 AA4 ALA A 98 VAL A 105 1 8 HELIX 5 AA5 VAL A 112 LEU A 122 1 11 HELIX 6 AA6 ASP A 124 GLY A 136 1 13 HELIX 7 AA7 GLY A 137 LEU A 148 1 12 HELIX 8 AA8 THR A 175 GLY A 189 1 15 HELIX 9 AA9 THR A 193 GLY A 206 1 14 HELIX 10 AB1 THR A 213 LEU A 218 5 6 HELIX 11 AB2 GLN A 262 ARG A 278 1 17 HELIX 12 AB3 GLN A 279 VAL A 281 5 3 HELIX 13 AB4 PHE B 22 GLN B 34 1 13 HELIX 14 AB5 PHE B 64 ALA B 78 1 15 HELIX 15 AB6 ASP B 90 LEU B 94 5 5 HELIX 16 AB7 ALA B 98 VAL B 105 1 8 HELIX 17 AB8 VAL B 112 LEU B 122 1 11 HELIX 18 AB9 ASP B 124 GLY B 136 1 13 HELIX 19 AC1 GLY B 137 LEU B 148 1 12 HELIX 20 AC2 THR B 175 PHE B 188 1 14 HELIX 21 AC3 THR B 193 GLY B 206 1 14 HELIX 22 AC4 THR B 213 LEU B 218 5 6 HELIX 23 AC5 GLN B 262 ARG B 278 1 17 HELIX 24 AC6 GLN B 279 VAL B 281 5 3 HELIX 25 AC7 PHE C 22 GLN C 34 1 13 HELIX 26 AC8 PHE C 64 ALA C 78 1 15 HELIX 27 AC9 ASP C 90 LEU C 94 5 5 HELIX 28 AD1 ALA C 98 VAL C 105 1 8 HELIX 29 AD2 VAL C 112 LEU C 122 1 11 HELIX 30 AD3 ASP C 124 GLY C 136 1 13 HELIX 31 AD4 GLY C 137 LEU C 148 1 12 HELIX 32 AD5 THR C 175 GLY C 189 1 15 HELIX 33 AD6 THR C 193 GLY C 206 1 14 HELIX 34 AD7 THR C 213 LEU C 218 5 6 HELIX 35 AD8 GLN C 262 GLN C 279 1 18 HELIX 36 AD9 PHE D 22 GLN D 34 1 13 HELIX 37 AE1 PHE D 64 ALA D 78 1 15 HELIX 38 AE2 ASP D 90 LEU D 94 5 5 HELIX 39 AE3 ALA D 98 VAL D 105 1 8 HELIX 40 AE4 VAL D 112 LEU D 122 1 11 HELIX 41 AE5 ASP D 124 GLY D 136 1 13 HELIX 42 AE6 GLY D 137 LEU D 148 1 12 HELIX 43 AE7 THR D 166 ARG D 171 5 6 HELIX 44 AE8 THR D 175 GLY D 189 1 15 HELIX 45 AE9 THR D 193 GLY D 206 1 14 HELIX 46 AF1 THR D 213 LEU D 218 5 6 HELIX 47 AF2 GLN D 262 GLN D 279 1 18 SHEET 1 AA1 5 LEU A 48 TYR A 52 0 SHEET 2 AA1 5 LYS A 36 SER A 43 -1 N LEU A 41 O ILE A 49 SHEET 3 AA1 5 LYS A 249 ASN A 257 -1 O TYR A 255 N GLY A 38 SHEET 4 AA1 5 GLY A 235 ILE A 243 -1 N ALA A 240 O LEU A 252 SHEET 5 AA1 5 VAL A 223 CYS A 231 -1 N GLY A 229 O ASN A 237 SHEET 1 AA2 2 PHE A 58 ALA A 59 0 SHEET 2 AA2 2 THR A 173 THR A 174 -1 O THR A 174 N PHE A 58 SHEET 1 AA3 2 LYS A 86 HIS A 88 0 SHEET 2 AA3 2 TYR A 109 THR A 111 -1 O MET A 110 N LEU A 87 SHEET 1 AA4 5 LEU B 48 TYR B 52 0 SHEET 2 AA4 5 LYS B 36 SER B 43 -1 N LEU B 41 O ILE B 49 SHEET 3 AA4 5 LYS B 249 ASN B 257 -1 O TYR B 255 N GLY B 38 SHEET 4 AA4 5 GLY B 235 ILE B 243 -1 N ALA B 240 O LEU B 252 SHEET 5 AA4 5 VAL B 223 CYS B 231 -1 N GLY B 229 O ASN B 237 SHEET 1 AA5 2 PHE B 58 ALA B 59 0 SHEET 2 AA5 2 THR B 173 THR B 174 -1 O THR B 174 N PHE B 58 SHEET 1 AA6 2 LYS B 86 HIS B 88 0 SHEET 2 AA6 2 TYR B 109 THR B 111 -1 O MET B 110 N LEU B 87 SHEET 1 AA7 5 LEU C 48 TYR C 52 0 SHEET 2 AA7 5 LYS C 36 SER C 43 -1 N LEU C 41 O ILE C 49 SHEET 3 AA7 5 LYS C 249 ASN C 257 -1 O TYR C 255 N GLY C 38 SHEET 4 AA7 5 GLY C 235 ILE C 243 -1 N ALA C 240 O LEU C 252 SHEET 5 AA7 5 VAL C 223 CYS C 231 -1 N GLY C 229 O ASN C 237 SHEET 1 AA8 2 PHE C 58 ALA C 59 0 SHEET 2 AA8 2 THR C 173 THR C 174 -1 O THR C 174 N PHE C 58 SHEET 1 AA9 2 LYS C 86 HIS C 88 0 SHEET 2 AA9 2 TYR C 109 THR C 111 -1 O MET C 110 N LEU C 87 SHEET 1 AB1 5 LEU D 48 TYR D 52 0 SHEET 2 AB1 5 LYS D 36 SER D 43 -1 N LEU D 41 O ILE D 49 SHEET 3 AB1 5 LYS D 249 ASN D 257 -1 O TYR D 255 N GLY D 38 SHEET 4 AB1 5 GLY D 235 ILE D 243 -1 N ALA D 240 O LEU D 252 SHEET 5 AB1 5 VAL D 223 CYS D 231 -1 N GLY D 225 O PHE D 241 SHEET 1 AB2 2 PHE D 58 ALA D 59 0 SHEET 2 AB2 2 THR D 173 THR D 174 -1 O THR D 174 N PHE D 58 SHEET 1 AB3 2 LYS D 86 HIS D 88 0 SHEET 2 AB3 2 TYR D 109 THR D 111 -1 O MET D 110 N LEU D 87 SSBOND 1 CYS A 61 CYS A 231 1555 1555 2.04 SSBOND 2 CYS B 61 CYS B 231 1555 1555 2.00 SSBOND 3 CYS C 61 CYS C 231 1555 1555 2.06 SSBOND 4 CYS D 61 CYS D 231 1555 1555 1.99 LINK OG SER A 62 C7 ID1 A 303 1555 1555 1.40 LINK OG SER B 62 C7 ID1 B 302 1555 1555 1.43 LINK OG SER C 62 C7 ID1 C 302 1555 1555 1.42 LINK OG SER D 62 C7 ID1 D 302 1555 1555 1.39 CISPEP 1 GLU A 159 PRO A 160 0 -7.48 CISPEP 2 GLU C 159 PRO C 160 0 -4.61 SITE 1 AC1 4 CYS A 61 SER A 62 THR A 63 ASN A 237 SITE 1 AC2 3 SER A 43 ASN A 45 LYS B 197 SITE 1 AC3 11 CYS A 61 SER A 62 LYS A 65 TYR A 97 SITE 2 AC3 11 SER A 123 ASN A 125 GLU A 159 THR A 228 SITE 3 AC3 11 GLY A 229 SER A 230 HOH A 495 SITE 1 AC4 4 CYS B 61 SER B 62 THR B 63 ASN B 237 SITE 1 AC5 6 HIS A 283 ALA B 59 ASP B 169 HOH B 462 SITE 2 AC5 6 HOH B 466 HOH B 467 SITE 1 AC6 5 MET C 60 CYS C 61 SER C 62 THR C 63 SITE 2 AC6 5 ASN C 237 SITE 1 AC7 4 CYS D 61 SER D 62 THR D 63 ASN D 237 SITE 1 AC8 12 MET B 60 CYS B 61 THR B 63 PHE B 64 SITE 2 AC8 12 LYS B 65 SER B 123 ASN B 125 THR B 228 SITE 3 AC8 12 GLY B 229 SER B 230 CL B 301 HOH B 421 SITE 1 AC9 16 MET C 60 CYS C 61 THR C 63 PHE C 64 SITE 2 AC9 16 LYS C 65 TYR C 97 SER C 123 ASN C 125 SITE 3 AC9 16 GLU C 159 THR C 209 LYS C 227 THR C 228 SITE 4 AC9 16 GLY C 229 SER C 230 CL C 301 HOH C 429 SITE 1 AD1 14 MET D 60 CYS D 61 THR D 63 PHE D 64 SITE 2 AD1 14 LYS D 65 TYR D 97 SER D 123 ASN D 125 SITE 3 AD1 14 THR D 228 GLY D 229 SER D 230 CL D 301 SITE 4 AD1 14 HOH D 470 HOH D 484 CRYST1 53.980 95.860 103.420 90.00 91.97 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018525 0.000000 0.000637 0.00000 SCALE2 0.000000 0.010432 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009675 0.00000